there is no established or approved treatment for schizophrenia in humans using FRAX486 or Bio 30 Propolis. It is crucial to understand that findings from animal studies, such as those conducted in mice, do not always directly translate to effective treatments in humans.
While PAK1 inhibition might have shown promise in certain animal studies for schizophrenia, the path to developing a safe and effective treatment for humans is complex and requires extensive research and clinical trials.
There are several reasons why Bio 30 Propolis or other PAK1 inhibitors might not be explored extensively or immediately for schizophrenia treatment:
Efficacy: Even if a substance demonstrates efficacy in animal models, it may not have the same effect in humans due to differences in biology and disease complexity.
Safety: Safety is of utmost importance when developing drugs for human use. Potential side effects and long-term consequences of PAK1 inhibition need to be thoroughly investigated before any human trials can be considered.
Lack of clinical evidence: To establish the effectiveness of a treatment for schizophrenia in humans, multiple rigorous clinical trials involving a significant number of patients are necessary. so I recommend checking more recent scientific literature, clinical trials, and credible sources for the latest information on potential treatments for schizophrenia. If you or someone you know is seeking treatment for schizophrenia, it is crucial to consult with qualified healthcare professionals who can provide the most appropriate and evidence-based care.